Kraft Foods Licenses Portfolio of New Ingredients from Medisyn Technologies (KFT)

Medisyn Technologies said that Kraft Foods KFT has entered into a licensing agreement for a portfolio of novel ingredients that have been uncovered during a two year collaboration between the two companies. The compounds may provide benefits for health and wellness. For Kraft Foods, the collaboration is part of a larger open innovation strategy to seek outside innovators and more quickly meet the latest consumer needs and market opportunities.
Market News and Data brought to you by Benzinga APIs
Comments
Loading...
Posted In: NewsContractsConsumer StaplesPackaged Foods & Meats
Benzinga simplifies the market for smarter investing

Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.

Join Now: Free!